More on INKT

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (7.5 Score)

Upcoming Events

- Earnings (3/18/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

MiNK Therapeutics (NQ:INKT)
Delayed: 10.28 -0.67 (6.12%)
Prev. Close $10.95  
Open$10.61 
52 Wk High$ 
52 Wk Low$ 
Day High$10.72 
Day Low$10.17 
P/E N/A  
EPS$ 
Volume6,222 

Friends, Peers and Foes (?): AGEN (more...)

Mar 4, 2026 04:45 PM Form 4 MiNK Therapeutics, Inc. For: Feb 27 Filed by: Ryan Barbara
Feb 3, 2026 09:30 PM MiNK Therapeutics Presents New Data of allo-iNKT Cell Therapy as a Potential Disease-Modifying Approach in Idiopathic Pulmonary Fibrosis at Keystone Symposia
Jan 14, 2026 04:05 PM Form 4/A MiNK Therapeutics, Inc. For: Jan 02 Filed by: Buell Jennifer
Jan 8, 2026 12:00 PM MiNK Therapeutics begins phase 1 trial for stem cell transplant therapy
Jan 8, 2026 12:00 PM MiNK Therapeutics and University of Wisconsin–Madison Announce Phase 1 Clinical Trial of Allo-iNKT Cell Therapy (AgenT-797) to Evaluate Prevention of Graft-Versus-Host Disease
Jan 6, 2026 05:27 PM Form 4 MiNK Therapeutics, Inc. For: Jan 02 Filed by: Buell Jennifer
Jan 6, 2026 05:24 PM Form 4 MiNK Therapeutics, Inc. For: Jan 02 Filed by: WIINBERG ULF
Jan 6, 2026 05:22 PM Form 4 MiNK Therapeutics, Inc. For: Jan 02 Filed by: Ryan Barbara
Jan 6, 2026 05:22 PM Form 4 MiNK Therapeutics, Inc. For: Jan 02 Filed by: Corvese Brian
Jan 6, 2026 05:20 PM Form 4 MiNK Therapeutics, Inc. For: Jan 02 Filed by: Behner Peter
View All Articles

Entities mentioned with INKT

View All Entities